Molecular docking investigation of the binding interactions of macrocyclic inhibitors with HCV NS3 protease and its mutants (R155K, D168A and A156V).
about
Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals.Evaluating Andrographolide as a Potent Inhibitor of NS3-4A Protease and Its Drug-Resistant Mutants Using In Silico ApproachesConformational transition pathway in the inhibitor binding process of human monoacylglycerol lipase.
P2860
Molecular docking investigation of the binding interactions of macrocyclic inhibitors with HCV NS3 protease and its mutants (R155K, D168A and A156V).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Molecular docking investigatio ...... ants (R155K, D168A and A156V).
@en
Molecular docking investigatio ...... ants (R155K, D168A and A156V).
@nl
type
label
Molecular docking investigatio ...... ants (R155K, D168A and A156V).
@en
Molecular docking investigatio ...... ants (R155K, D168A and A156V).
@nl
prefLabel
Molecular docking investigatio ...... ants (R155K, D168A and A156V).
@en
Molecular docking investigatio ...... ants (R155K, D168A and A156V).
@nl
P2093
P2860
P1433
P1476
Molecular docking investigatio ...... ants (R155K, D168A and A156V).
@en
P2093
Ahmed A Ezat
Hamdy I A Mostafa
Nihal S El-Bialy
P2860
P2888
P356
10.1007/S10930-013-9538-6
P577
2014-02-01T00:00:00Z